To evaluate bleeding risk in interventional procedures in patients with or without antiplatelet and/or anticoagulant therapy.~To evaluate differences in outcomes in patients not receiving any anticoagulant or antiplatelet therapy compared to patients receiving various types of drugs with anticoagulant or antiplatelet therapeutic effects.~To evaluate and compare the adverse event profiling all patients.
This study will evaluate bleeding risk and differences in outcomes in patients receiving and not receiving anticoagulant or antiplatelet therapy